Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
QuintilesIMS
Fuji
McKinsey
McKesson
Chubb
Harvard Business School
Argus Health
Baxter

Generated: December 11, 2017

DrugPatentWatch Database Preview

UPTRAVI Drug Profile

« Back to Dashboard

Summary for UPTRAVI

Drug patent expirations by year for UPTRAVI

Pharmacology for UPTRAVI

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-007Dec 21, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-006Dec 21, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-008Dec 21, 2015RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-005Dec 21, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-006Dec 21, 2015RXYesNo► Subscribe► Subscribe► SubscribeYY► Subscribe
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-005Dec 21, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-001Dec 21, 2015RXYesNo► Subscribe► Subscribe► SubscribeYY► Subscribe
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-003Dec 21, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-004Dec 21, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Actelion Pharms LtdUPTRAVIselexipagTABLET;ORAL207947-007Dec 21, 2015RXYesNo► Subscribe► Subscribe► SubscribeYY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: UPTRAVI

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,340,516Form-II crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsu- lfonyl) acetamide, method for producing the same, and use thereof► Subscribe
9,597,331Therapeutic compositions containing macitentan► Subscribe
8,809,334Therapeutic compositions containing macitentan► Subscribe
9,440,931Form-III crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsu- lfonyl)acetamide and use thereof► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: UPTRAVI

Country Document Number Estimated Expiration
BrazilPI0209249► Subscribe
Morocco33637► Subscribe
South Korea101678699► Subscribe
Israel216928► Subscribe
Argentina073031► Subscribe
Russian Federation2519161► Subscribe
China1516690► Subscribe
China104326991► Subscribe
Portugal1400518► Subscribe
Australia2010263569► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: UPTRAVI

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0836Netherlands► SubscribePRODUCT NAME: SELEXIPAG OF EEN ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/15/1083 20160519
2016000077Germany► SubscribePRODUCT NAME: SELEXIPAG ODER SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1083/001-010 20160512
2016 00048Denmark► SubscribePRODUCT NAME: SELEXIPAG ELLER ET SALT DERAF; REG. NO/DATE: EU/1/15/1083 20160519
90044-1Sweden► SubscribePRODUCT NAME: SELEXIPAG OR SALT THEROF; REG. NO/DATE: EU/1/15/1083 20160519
266Luxembourg► SubscribePRODUCT NAME: SELEXIPAG OU UN SEL DE CELUI-CI; FIRST REGISTRATION DATE: 20160519
C0042France► SubscribePRODUCT NAME: SELEXIPAG OU L'UN DE SES SELS; REGISTRATION NO/DATE: EU/1/15/1083 20160519
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Fish and Richardson
Chubb
Daiichi Sankyo
QuintilesIMS
Farmers Insurance
Covington
Cantor Fitzgerald
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot